ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meeting Abstracts
    • All Meetings
    • PRSYM 2026
    • ACR Convergence 2025
    • Download Abstract Supplements
  • Keyword Index
  • Search
  • My Favorites
    • View and print all favorites
    • Clear all favorites

Session » Spondyloarthritis Including Psoriatic Arthritis – Diagnosis, Manifestations, & Outcomes Poster I: Psoriatic Arthritis

Date: Friday, November 6, 2020

Time: 9:00AM-11:00AM

Meeting: ACR Convergence 2020

9:00AM-11:00AM
Abstract Number: 0305
A Delphi Consensus Study to Standardize Terminology for the Pre-clinical Phase of Psoriatic Arthritis
9:00AM-11:00AM
Abstract Number: 0314
Accuracy of Physical Examination to Detect Synovial and Extra-synovial Pathologies in Psoriatic Arthritis in Comparison to Ultrasonography
9:00AM-11:00AM
Abstract Number: 0336
Anxiety and Depression in Psoriatic Arthritis (PsA) – Prevalence and Impact on Patient Reported Outcomes: Real-World Survey in the US and Europe
9:00AM-11:00AM
Abstract Number: 0320
Assessment of Implementation of Treat to Target Concept Using Validated Composite Scores in Psoriatic Arthritis Patients
9:00AM-11:00AM
Abstract Number: 0317
Axial Involvement in Psoriatic Arthritis in a Comprehensive Rapid Diagnosis Program (Reuma-check PsA). Analysis of Its Characteristics
9:00AM-11:00AM
Abstract Number: 0306
Characteristics of Patients with Early Oligoarticular Psoriatic Arthritis in the Corrona Psoriatic Arthritis/Spondyloarthritis Registry
9:00AM-11:00AM
Abstract Number: 0343
Co-expression of DC-STAMP and CX3CR1: Biomarkers for Tissue Resident Osteoclasts in Psoriatic Arthritis
9:00AM-11:00AM
Abstract Number: 0333
Comparative Effectiveness of Secukinumab, Adalimumab and Other Tumor Necrosis Factor Inhibitors Used with or Without Methotrexate in the Treatment of Psoriatic Arthritis
9:00AM-11:00AM
Abstract Number: 0334
Comparative Efficacy of Guselkumab in Patients with Psoriatic Arthritis: Results from Systematic Literature Review and Network Meta-Analysis
9:00AM-11:00AM
Abstract Number: 0324
Comparative Responsiveness of Outcome Measures in Psoriatic Arthritis: Preparation for Pragmatic Trials
9:00AM-11:00AM
Abstract Number: 0312
Dactylitis Is Associated with Greater Disease Severity, Ultrasound Synovitis, and Erosive Damage, in Very Early DMARD Naïve Psoriatic Arthritis
9:00AM-11:00AM
Abstract Number: 0308
Delay in Transition from Psoriasis to Psoriatic Arthritis: A Population Based Study
9:00AM-11:00AM
Abstract Number: 0322
Development and Preliminary Validation of Smartphone Sensor-based Measurement Tools for Psoriatic Arthritis
9:00AM-11:00AM
Abstract Number: 0309
Diagnostic Delay in Psoriatic Arthritis: A Population Based Study
9:00AM-11:00AM
Abstract Number: 0326
Flares Among Patients with Psoriatic Arthritis (PsA) – Frequency and Impact on Patient Outcomes: Real-world Survey in the US and Europe
9:00AM-11:00AM
Abstract Number: 0332
Guselkumab Improved Work Productivity and Daily Activity in Patients with Psoriatic Arthritis: Results from a Phase 3 Trial
9:00AM-11:00AM
Abstract Number: 0328
Healthcare Utilization and Costs Among Patients with Psoriatic Arthritis and Psoriasis in the United States – a Retrospective Study of Claims Data from 2009 to 2020
9:00AM-11:00AM
Abstract Number: 0329
Healthcare Utilization and Costs Associated with Functional Status in Patients with Psoriatic Arthritis
9:00AM-11:00AM
Abstract Number: 0316
High-sensitivity 18F-FDG PET/CT: A Diagnostic Tool for Psoriatic Arthritis
9:00AM-11:00AM
Abstract Number: 0338
Increased Risk of Lymphoproliferative Disorders in Psoriatic Arthritis
9:00AM-11:00AM
Abstract Number: 0335
Interleukin-17 Blockade Leads to Shifts from Stage-based Towards Response-based Disease Clusters- Comparative Data from Very Early and Established Psoriatic Arthritis
9:00AM-11:00AM
Abstract Number: 0339
Is Sex-adjusted Treatment in Early-PsA Justified?
9:00AM-11:00AM
Abstract Number: 0307
Longitudinal Analysis of the Patient Pathways to Diagnosis of Psoriatic Arthritis
9:00AM-11:00AM
Abstract Number: 0341
Metabolomics Profiling of Human Serum for Discovering Biomarkers to Diagnose Psoriatic Arthritis and Ankylosing Spondylitis with High Specificity
9:00AM-11:00AM
Abstract Number: 0342
Multimorbidity Clusters in Psoriatic Arthritis: A Population-Based Study
9:00AM-11:00AM
Abstract Number: 0330
Musculoskeletal Surgery in Psoriatic Arthritis: Prevalence and Risk Factors
9:00AM-11:00AM
Abstract Number: 0340
Neuropathic Pain Relationship with Comorbidity in Psoriatic Arthritis Patients and Its Influence on Disease Activity
9:00AM-11:00AM
Abstract Number: 0321
Outcome Measures in Psoriatic Arthritis Registries Are Very Heterogeneous: A Systematic Literature Review of 27 Registries, or 16183 Patients
9:00AM-11:00AM
Abstract Number: 0318
Oxylipin Profile Is Associated with Skin Disease and Enthesitis in Psoriatic Disease
9:00AM-11:00AM
Abstract Number: 0323
Residual Symptoms in Patients with PsA Who Are in Very Low Disease Activity According to Physician Assessments
9:00AM-11:00AM
Abstract Number: 0337
Similar Impact of Psoriatic Arthritis and Rheumatoid Arthritis on Objective and Subjective Parameters of Hand Function
9:00AM-11:00AM
Abstract Number: 0327
Skin Involvement in Psoriatic Arthritis (PsA) – The Incremental Impact of Psoriasis on Quality of Life, Disability and Work Productivity: Real-world Survey in US and Europe
9:00AM-11:00AM
Abstract Number: 0313
Swollen Joints but Not Tender Joints Are Associated with Ultrasound Power Doppler Synovitis in Very Early DMARD Naive Psoriatic Arthritis
9:00AM-11:00AM
Abstract Number: 0319
Target Outcomes in Psoriatic Arthritis: Simultaneous Achievement of ACR50-Psoriasis Area and Severity Index 100 and Beyond: Insights from Open-Label, Assessor-Blinded Study at Week 24
9:00AM-11:00AM
Abstract Number: 0325
The Impact of PsA Disease Control Status on Patient Treatment Satisfaction: Real-world Survey in US and Europe
9:00AM-11:00AM
Abstract Number: 0311
The Link Between Joints and Entheses in Psoriatic Arthritis: An Ultrasound Study Supporting the Synovio-entheseal Complex Theory
9:00AM-11:00AM
Abstract Number: 0310
The Prediction of Psoriatic Arthritis Tool (PRESTO) Study – Interim Report
9:00AM-11:00AM
Abstract Number: 0315
The Role of Ultrasound for the Assessment of Psoriatic Arthritis Patients with Fibromyalgia
9:00AM-11:00AM
Abstract Number: 0344
Use of the BASDAI in Psoriatic Arthritis Patients with and Without Axial Disease
9:00AM-11:00AM
Abstract Number: 0331
Work Absenteeism and Disability Associated with Psoriatic Arthritis and Psoriasis in the United States – A Retrospective Study of Claims Data from 2009 to 2020

« View all sessions from this meeting

Advanced Search

My Favorites

Save and print abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract (must have cookies enabled in browser). See saved favorites.

Abstract Policies

  • ACR Convergence Abstract Embargo Policies
  • ACR Convergence Abstract Permissions & Reprints
  • PRSYM Abstract Policies

ACR Convergence. Where Rheumatology Meets

ACR Convergence 2026

Join us November 6-11 in Orlando, Florida.
See Registration Information

  • Contact ACR
  • Privacy Policy
  • ACR Policies
  • Cookie Preferences

© Copyright 2026 American College of Rheumatology